Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$18,806
+$7,658 QoQ
Shares Held
120
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,497
of 1,603 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in NVS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,806 | 120 | Shares | Sole | 2026-07-20 | |
| 2025-03-31 | $11,148 | 100 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $9,731 | 100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,502 | 100 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $10,646 | 100 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $9,673 | 100 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $10,097 | 100 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $10,186 | 100 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $10,091 | 100 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $9,200 | 100 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $9,072 | 100 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $7,601 | 100 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $8,453 | 100 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $11,495 | 131 | Shares | Sole | 2023-12-19 | |
| 2020-06-30 | $7,161 | 82 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $19,623 | 238 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||